The government’s over-centralised and semi-privatised design was never going to turn out well, says public health academic David McCoy
Perspective from The New England Journal of Medicine — Up Is Down — Pharmaceutical Industry Caution vs. Federal Acceleration of Covid-19 Vaccine Approval
A new study has detailed the damaging role played by the immune system in a severe brain condition most commonly caused by the cold sore...
Launching a dual-pronged attack on tumours using a combination of two innovative precision medicines could treat patients with multiple common cancers, a new clinical trial shows.
Simon Bacon: "People want to see that we are working hard and we are getting a benefit out of all our sacrifice." ...
Australia’s Communicable Disease Genomics Network (CDGN) and American biotech company Illumina are collaborating to track COVID-19 using next-generation genomic sequencing technology, which enables real-time data sharing...
Researchers at The Australian National University (ANU) have developed a new blood test capturing previous exposure to COVID-19. Initial results suggest...
A shortage of COVID-19 testing in the U.K. is jeopardizing efforts to restore medical services and prepare for a potential surge in coronavirus cases this winter,...
These are the UK coronavirus stories you need to know about today.
Patients with gum disease should be told that they have a higher risk of suffering cardiovascular diseases - including myocardial infarction and stroke - and that...